KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLoansLoans - NetLong-Term InvestmentsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesReceivables - AccuredRetained EarningsSecurities - Held-to-maturitySecurities - TradableSecurities BorrowedSecurities BoughtShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Morgan Stanley (MS) Cash & Equivalents (2018 - 2025)

Morgan Stanley (MS) has disclosed Cash & Equivalents for 13 consecutive years, with $111.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 5.99% to $111.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $111.7 billion, a 5.99% increase, with the full-year FY2025 number at $111.7 billion, up 5.99% from a year prior.
  • Cash & Equivalents was $111.7 billion for Q4 2025 at Morgan Stanley, up from $103.7 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $136.1 billion in Q1 2022 to a low of $89.2 billion in Q4 2023.
  • A 5-year average of $113.2 billion and a median of $111.7 billion in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: rose 20.89% in 2021, then crashed 30.36% in 2023.
  • Morgan Stanley's Cash & Equivalents stood at $127.7 billion in 2021, then grew by 0.31% to $128.1 billion in 2022, then plummeted by 30.36% to $89.2 billion in 2023, then grew by 18.1% to $105.4 billion in 2024, then increased by 5.99% to $111.7 billion in 2025.
  • Per Business Quant, the three most recent readings for MS's Cash & Equivalents are $111.7 billion (Q4 2025), $103.7 billion (Q3 2025), and $105.4 billion (Q4 2024).